## MCK: McKesson Corporation - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 0.7% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($796.38)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. McKesson (MCK) Gets Higher Target at Deutsche Bank Despite Planned Spin-Off**
- Source: Finviz | 20251231T010833 | Bullish | Relevance: 100%
- Deutsche Bank analyst George Hill raised the price target on McKesson Corporation (NYSE:MCK) to $904 from $861, reiterating a Buy rating, despite the planned spin-off of its med-surgical business by the end of 2027. The company's fiscal 2026 profit forecast was raised earlier in November due to strong oncology and specialty drug distribution. Although revenue slightly missed expectations in the most recent quarter, the company's adjusted EPS significantly beat estimates.

**2. Accurate Wealth Management LLC Has $3.07 Million Position in McKesson Corporation $MCK**
- Source: MarketBeat | 20260101T081355 | Bullish | Relevance: 100%
- Accurate Wealth Management LLC significantly increased its stake in McKesson Corporation by 463.6% in the third quarter, now holding 3,928 shares valued at approximately $3.07 million. This move comes as McKesson outperformed EPS estimates with $9.86 versus $8.84 expected and reported a 10.2% year-over-year revenue increase to $103.15 billion. Analysts maintain a "Moderate Buy" consensus with a target price of $892.86, and institutional ownership remains high at 85.07%.

**3. Allspring Global Investments Holdings LLC Acquires 126,043 Shares of McKesson Corporation $MCK**
- Source: MarketBeat | 20260101T081355 | Bullish | Relevance: 100%
- Allspring Global Investments Holdings LLC significantly increased its stake in McKesson Corporation (NYSE:MCK) by 475.4% in the third quarter, purchasing an additional 126,043 shares to hold a total of 152,557 shares valued at approximately $116.7 million. This substantial investment comes as analysts maintain a "Moderate Buy" consensus rating for McKesson, with an average price target of $892.86, and the company recently reported strong Q3 earnings, beating EPS estimates, and declared a quarterly dividend.

**4. McKesson (NYSE:MCK) Shares Hold Flat Within NYSE Composite Index**
- Source: Kalkine Media | 20251231T121024 | Neutral | Relevance: 100%
- McKesson (NYSE:MCK) shares are holding flat within the NYSE Composite Index, performing consistently. The article provides a detailed look into McKesson Corporation's healthcare distribution activities, operational segments, and market positioning, emphasizing its supply chain infrastructure and technology-enabled services. It highlights the company's role in the healthcare sector and its inclusion in broad market indexes.

**5. Generate Investment Management Ltd Raises Stock Holdings in McKesson Corporation $MCK**
- Source: MarketBeat | 20251231T114457 | Bullish | Relevance: 100%
- Generate Investment Management Ltd significantly increased its stake in McKesson Corporation (NYSE:MCK) by 138.4% during the third quarter, now owning 20,267 shares valued at $15.66 million. Other institutional investors like Solstein Capital LLC and Abound Wealth Management also boosted their holdings. The report also details analyst ratings, insider transactions, and McKesson's recent financial performance and dividend announcement.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $960 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | init | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 1 ($0.28M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (-0.3%)
- Blackrock Inc.: 9.2% (+0.4%)
- State Street Corpora: 4.7% (+0.9%)
- JPMORGAN CHASE & CO: 4.5% (+16.0%)
- Massachusetts Financ: 3.2% (-1.5%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.00 indicates undervaluation relative to growth. Balance sheet: $2.3B free cash flow. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $102.4B |
| Beta | 0.38 |
| 52W Range | $570.51 - $895.58 |
| Short Interest | 1.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.00 |
| Forward P/E | 18.8 |
| Current P/E | 21.3 |
| YoY Growth | 13.3% |
| EPS Direction | STABLE |

### Technicals

MRS_10 improving modestly (+0.9% over 5 days). Below STRENGTH zone by 2.3pp (needs >3.0% for momentum thesis). MRS_5 at 0.4% confirms short-term momentum alignment. MACD histogram positive (0.99), confirming momentum. RSI neutral at 50. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.70% (CS: 49) | Neutral |
| RSI_14 | 49.8 | Neutral |
| MACD Histogram | 0.99 | Bullish |
| vs SMA20 | 1.009x | Above |
| vs SMA50 | 0.991x | Below |
| vs SMA200 | 1.114x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $823.44
- **Stop Loss:** $796.38 (3.3% risk)
- **Target:** $850.50 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 53
- **Position Value:** $43,642.32
- **Portfolio %:** 43.64%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-02-04 (Est: $9.28)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $9.05 | $9.86 | +8.9% |
| 2025Q2 | $8.15 | $8.26 | +1.4% |
| 2025Q1 | $9.83 | $10.12 | +3.0% |
| 2024Q4 | $7.99 | $8.03 | +0.5% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_10*